Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instromedix was a medical technology company that specialized in the design and manufacture of cardiac monitoring devices and systems. The company was a pioneer in the field of transtelephonic electrocardiogram (ECG) monitoring, which allowed patients to record heart rhythm data during symptomatic events and transmit it to healthcare providers via telephone. Its product line featured well-known ambulatory event recorders, such as the King of Hearts and Queen of Hearts series, used for diagnosing transient arrhythmias. In 1999, Medtronic acquired Instromedix for approximately $45 million to expand its cardiac rhythm management business. The Instromedix brand and assets were later sold by Medtronic to CardioNet (now part of Philips) in 2007.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instromedics.